U.S. markets open in 3 hours 44 minutes
  • S&P Futures

    4,560.00
    -5.25 (-0.11%)
     
  • Dow Futures

    35,599.00
    -45.00 (-0.13%)
     
  • Nasdaq Futures

    15,533.75
    -11.25 (-0.07%)
     
  • Russell 2000 Futures

    2,279.70
    -14.20 (-0.62%)
     
  • Crude Oil

    83.21
    -1.44 (-1.70%)
     
  • Gold

    1,787.20
    -6.20 (-0.35%)
     
  • Silver

    23.98
    -0.11 (-0.45%)
     
  • EUR/USD

    1.1594
    -0.0008 (-0.07%)
     
  • 10-Yr Bond

    1.6190
    0.0000 (0.00%)
     
  • Vix

    16.09
    +0.85 (+5.58%)
     
  • GBP/USD

    1.3732
    -0.0031 (-0.23%)
     
  • USD/JPY

    113.5890
    -0.5400 (-0.47%)
     
  • BTC-USD

    58,961.30
    -3,709.74 (-5.92%)
     
  • CMC Crypto 200

    1,415.91
    -89.24 (-5.93%)
     
  • FTSE 100

    7,257.07
    -20.55 (-0.28%)
     
  • Nikkei 225

    29,098.24
    -7.77 (-0.03%)
     

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ARDX, PHG and HYRE

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / September 9, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Ardelyx, Inc. (NASDAQ:ARDX)
Class Period: August 6, 2020 - July 19, 2021
Lead Plaintiff Deadline: September 28, 2021

The complaint alleges that during the class period Ardelyx, Inc. made materially false and/or misleading statements and/or failed to disclose that: 1) the Company overstated the likelihood that tenapanor would be approved by the Food and Drug Administration ("FDA"); and 2) Defendants possessed, were in control over, and as a result, knew that the data submitted to support the New Drug Application was insufficient in that it showed a lack of clinical relevance of the drug's treatment effect, making it foreseeably likely that the FDA would not approve the drug.

Learn about your recoverable losses in ARDX: https://www.kleinstocklaw.com/pslra-1/ardelyx-inc-loss-submission-form?id=19422&from=1

Koninklijke Philips N.V. (NYSE:PHG)
Class Period: February 25, 2020 - June 11, 2021
Lead Plaintiff Deadline: October 15, 2021

Throughout the class period, Koninklijke Philips N.V. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Philips had deficient product manufacturing controls or procedures; (ii) as a result, the Company's Bi-Level PAP and CPAP devices and mechanical ventilators were manufactured using hazardous materials; (iii) accordingly, the Company's sales revenues from the foregoing products were unsustainable; (iv) the foregoing also subjected the Company to a substantial risk of a product recall, in addition to potential legal and/or regulatory action; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in PHG: https://www.kleinstocklaw.com/pslra-1/koninklijke-philips-n-v-loss-submission-form?id=19422&from=1

HyreCar Inc. (NASDAQ:HYRE)
Class Period: May 14, 2021 - August 10, 2021
Lead Plaintiff Deadline: October 26, 2021

During the class period, HyreCar Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) HyreCar had materially understated its insurance reserves; (b) HyreCar had systematically failed to pay valid insurance claims incurred prior to the Class Period; (c) HyreCar had incurred significant expenses transitioning to its new third-party insurance claims administrator and processing claims incurred from prior periods; (d) HyreCar had failed to appropriately price risk in its insurance products and was experiencing elevated claims incidence as a result; (e) HyreCar had been forced to dramatically reform its claims underwriting, policies and procedures in response to unacceptably high claims severity and customer complaints; and (f) as a result, HyreCar's operations and prospects were misrepresented because the Company was not on track to meet the financial estimates provided to investors during the Class Period, and such estimates lacked a reasonable basis in fact, including HyreCar's purported gross margin, EBITDA (earnings before interest, taxes, depreciation, and amortization), and net loss trajectories.

Learn about your recoverable losses in HYRE: https://www.kleinstocklaw.com/pslra-1/hyrecar-inc-loss-submission-form?id=19422&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/663313/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-ARDX-PHG-and-HYRE